- Trials with a EudraCT protocol (9)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
9 result(s) found for: Radial Nerve.
Displaying page 1 of 1.
EudraCT Number: 2016-002835-14 | Sponsor Protocol Number: SCCCSH01 | Start Date*: 2016-10-07 | |||||||||||
Sponsor Name:Nordsjællands Hospital Hillerød | |||||||||||||
Full Title: Supraclavicular catheter for regional anesthesia of the shoulder - an explorative study in healthy volunteers. | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011829-13 | Sponsor Protocol Number: AN09/8905 | Start Date*: 2009-11-02 |
Sponsor Name:University of Leeds | ||
Full Title: What is the ED95 dose for bupivacaine for supraclavicular brachial plexus block using ultrasound? | ||
Medical condition: Patients presenting for routine upper limb surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-002810-15 | Sponsor Protocol Number: CHUB-Neuro-ENMG-MS | Start Date*: 2021-06-25 | |||||||||||
Sponsor Name:CHU Brugmann | |||||||||||||
Full Title: Peripheral neuropathy as potential side effect in patients with multiple sclerosis treated with teriflunomide. | |||||||||||||
Medical condition: Multiple sclerosis, treated with teriflunomide | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004980-39 | Sponsor Protocol Number: Amiloride02 | Start Date*: 2013-01-21 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: A double blind randomised controlled trial on neuroprotection of amiloride in optic neuritis | |||||||||||||
Medical condition: Optic Neuritis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002378-19 | Sponsor Protocol Number: CLN-PXT3003-02 | Start Date*: 2015-08-27 | |||||||||||
Sponsor Name:PHARNEXT | |||||||||||||
Full Title: International, multi-center, randomized, double-blind, placebo-controlled phase III study assessing in parallel groups the efficacy and safety of 2 doses of PXT3003 in patients with Charcot-Marie-T... | |||||||||||||
Medical condition: Charcot-Marie-Tooth Disease - Type 1A | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DE (Suspended by CA) ES (Completed) BE (Completed) GB (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000986-30 | Sponsor Protocol Number: 140109 | Start Date*: 2015-03-03 | |||||||||||
Sponsor Name:IRCCS Ospedale San Raffaele U.O. Oculistica | |||||||||||||
Full Title: Intravitreal Aflibercept for Choroidal Neovascularization Secondary to Angioid Streaks (EYLEA-STRIE) | |||||||||||||
Medical condition: Choroidal neovascularization secondary to angioid streaks . | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000585-30 | Sponsor Protocol Number: I16016 | Start Date*: 2017-12-13 | ||||||||||||||||
Sponsor Name:CHU de Limoges | ||||||||||||||||||
Full Title: Pilot study, single-blind, candesartan versus usual care of peripheral neuropathy development induced by vincristine (PNIV) in patients treated for lymphoma B. | ||||||||||||||||||
Medical condition: peripheral neuropathy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-003561-17 | Sponsor Protocol Number: 750CNP01 | Start Date*: 2020-01-23 | |||||||||||
Sponsor Name:Toray Industries, Inc. | |||||||||||||
Full Title: A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TRK-750 in Colorectal Cancer Patients with Chemotherapy-induced Peripheral Neuropathy Following Oxaliplatin-con... | |||||||||||||
Medical condition: Chemotherapy-induced peripheral neuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Prematurely Ended) ES (Prematurely Ended) DK (Prematurely Ended) FR (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002379-81 | Sponsor Protocol Number: CLN-PXT3003-03 | Start Date*: 2017-01-26 | |||||||||||
Sponsor Name:Pharnext | |||||||||||||
Full Title: International, multi-center, double blind 9-month FOLLOW-UP extension study assessing the long term safety and tolerability of PXT3003 in patients with Charcot-Marie-Tooth Disease type 1A. | |||||||||||||
Medical condition: Charcot-Marie-Tooth Disease type 1A | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) DE (Suspended by CA) BE (Completed) NL (Completed) ES (Prematurely Ended) GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.